**Question:** On November 6, a patient had the onset of an illness characterized by fever, chills, headache, cough, and chest pain. The illness lasted 1 week. On December 5, she had another illness very similar to the first, which lasted 6 days. She had no influenza immunization during this period. Her hemagglutination inhibition antibody titers to nH1N1 influenza virus were as follows: November 6: 10, November 30: 10, December 20: 160 There was no laboratory error. Which of the following is the best conclusion from these data?

A. The patient developed natural immunity by recovering from the first illness
B. The patient received a booster dose of influenza vaccine
C. The patient developed immunity by receiving a previous influenza vaccination
D. The patient developed immunity by receiving an unrelated illness

**Correct Answer:**

**Core Concept:**
Hemagglutination inhibition (HI) assay is a laboratory test that measures the presence of influenza-specific antibodies in a patient's serum. A higher titer indicates a higher antibody concentration and immune response to the influenza virus.

**Why the Correct Answer is Right:**

The correct answer is A: The patient developed natural immunity by recovering from the first illness.

The patient's antibody titers increased during the illness and then decreased after recovery, indicating a primary immune response to the nH1N1 influenza virus. The titers rose again after the second illness, suggesting a secondary immune response to the same virus. This pattern is consistent with the development of immunity through natural infection (immunity by recovery from the first illness).

**Why Other Options are Incorrect:**

Option B (vaccine) and C (previous vaccination) are incorrect because there is no mention of the patient receiving a vaccine in the question. Option D (an unrelated illness) is incorrect because the patient's antibody titers increased after both illnesses, indicating a response to the same virus in both cases.

**Clinical Pearls:**

1. HI assay results demonstrate the patient developed immunity through recovering from the first illness, which is common in the natural infection process.
2. The patient's immune response increased after each illness, indicating a successful immune response to the nH1N1 influenza virus.
3. The HI assay can be a useful tool for assessing immune response and vaccine efficacy, but in this case, it demonstrates immunity development upon natural infection.